The process of bringing a vaccine to market takes extensive research and safety monitoring. Dr. Gordon Douglas explains the steps from preclinical studies to vaccine licensure, and discusses his own experience developing vaccines at a major manufacturer for 30 years. He also shares lessons learned from clinical trials during the COVID-19 pandemic, including the importance of participant diversity.
Guest: R. Gordon Douglas, Jr, MD
Professor Emeritus, Weill Cornell Medical College
Host: Jo-Ana Chase, PhD, APRN-BC
Associate Professor, Sinclair School of Nursing, University of Missouri Health
This podcast episode is supported by Seqirus. Content was developed by The Gerontological Society of America (GSA).
Create your
podcast in
minutes
It is Free